全球微生物發酵技術市場規模（按產品類型、應用、地區、範圍和預測）

微生物發酵技術的市場規模及預測

預計微生物發酵技術市場規模在 2024 年將達到 305.6 億美元，到 2032 年將達到 451.4 億美元，2026 年至 2032 年的複合年成長率為 5%。

微生物發酵技術是指在特定環境條件下控制細菌、酵母和真菌等微生物的生長發育，從而生產有價值的產品。它利用微生物的代謝能力，透過生化反應將原料轉化為所需的分子。發酵可以在有氧（有氧）或厭氧（無氧）條件下進行，這取決於微生物種類和預期結果。該技術最初用於食品和飲料生產，但後來擴展到藥品、化學品、生質燃料，甚至生物分解性塑膠。

發酵法廣泛應用於各行各業。它在優格、起司和麵包等發酵食品的生產中發揮著重要作用。在製藥業，它用於生產抗生素、疫苗和治療性蛋白質。在化學工業中，發酵產生的有機酸、酵素和胺基酸可用於各種產品。

微生物發酵市場顯著擴張與創新。基因工程和合成生物學的進步正在提高微生物菌株的進化能力，並使其針對特定產品進行最佳化，從而提高產量和效率。永續實踐和向循環經濟的轉變預計將推動微生物發酵領域的進一步研發，尤其是在生物基產品和再生能源來源。

微生物發酵技術的全球市場動態

影響全球微生物發酵技術市場的關鍵市場動態

關鍵市場促進因素

生物基產品需求不斷成長微生物發酵技術市場的發展受到客戶對永續和天然產品日益成長的需求的推動。根據美國農業部的報告，預計到2024年，全球生物基產品市場規模將達到4,872億美元。

食品和飲料行業的應用日益廣泛：微生物發酵在食品和飲料行業被廣泛採用，尤其是在益生菌和發酵食品的生產中。國際益生菌協會預測，到2023年，全球益生菌市場規模將達到693億美元，2018年至2023年的複合年成長率為7.0%。

製藥業應用不斷擴展：微生物發酵正擴大用於生產抗生素和酵素等藥物。根據世界衛生組織 (WHO) 的數據，預計到 2025 年，全球抗生素產業的價值將達到 503.7 億美元，其中發酵技術將佔產量的很大一部分。

主要挑戰

製程最佳化與規模化生產的主要挑戰之一是最佳化發酵操作，以實現最佳的生產力、純度和效率。從實驗室規模生產到工業規模生產，通常需要克服許多技術挑戰，例如維持穩定的環境條件、確保無菌、控制發酵動力學。原料和微生物菌株的變異性也會阻礙規模化生產，需要投入大量的研發資金。

產品多樣化和市場需求：滿足市場對新產品和新應用的不同需求需要持續創新和適應性。微生物發酵技術必須跟上不斷變化的客戶需求、科學進步和環境目標。開發新的微生物菌株、根據特定產品客製化發酵條件以及展現出優於傳統替代品的卓越性能，這些都是提升市場相關性和競爭力的持續挑戰。

技術整合與數位化：將發酵製程與自動化、人工智慧和巨量資料分析等數位技術結合，既帶來了機遇，也帶來了挑戰。數位化可以改善製程控制、提高效率並提升產品質量，但成功整合這些技術需要在基礎設施、經驗和資料管理能力方面進行大量投資。

主要趨勢：

生物製藥的擴展：微生物發酵擴大用於生產抗體、疫苗和治療性蛋白質等生物製藥。基因工程和生物製程最佳化的進步使得能夠以更高的產量和更低的價格生產複合化合物，從而促進了微生物發酵在生物製藥領域的應用。

永續生物基產品的興起：環境永續性意識的不斷增強，推動市場朝向生物基產品邁進。微生物發酵透過將可再生原料轉化為生物分解性的聚合物、生質燃料和綠色化學品，為標準化學合成過程提供了永續的替代方案。消費者對環保產品的偏好以及鼓勵生物經濟發展的監管獎勵推動了這一趨勢。

應用多樣化：微生物發酵正在食品和製藥等成熟產業之外尋找新的應用。農業、化妝品、紡織和生質能源產業越來越依賴微生物發酵來生產酵素、偏好、香料、生物農藥和生物肥料。這種多樣性源於微生物發酵的多功能性以及根據工業需求量身定做產品的能力。

目錄

第1章全球微生物發酵技術市場介紹

• 市場概覽
• 研究範圍
• 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

• 資料探勘
• 驗證
• 第一手資料
• 資料來源列表

第4章 微生物發酵技術全球市場展望

• 概述
• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 波特五力模型
• 價值鏈分析

第5章 全球微生物發酵技術市場依產品類型分類

• 概述
• 酵素
• 抗生素
• 有機酸
• 維他命
• 生物聚合物

第6章 全球微生物發酵技術市場（依應用）

• 概述
• 製藥
• 飲食
• 農業
• 工業化學品
• 環境保護

第7章 全球微生物發酵技術市場（按地區）

• 概述
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 世界其他地區
  • 拉丁美洲
  • 中東和非洲

第8章全球微生物發酵技術市場競爭格局

• 概述
• 各公司市場排名
• 主要發展策略

第9章 公司簡介

• F. Hoffmann-La Roche AG
• Koninklijke DSM NV
• Lonza Group AG
• Novozymes A/S
• Danone Ltd.
• Amyris, Inc.
• Biocon Ltd.
• TerraVia Holdings, Inc.
• BioVectra Inc
• United Breweries Ltd

第10章 附錄

• 相關調查

Microbial Fermentation Technology Market Size And Forecast

Microbial Fermentation Technology Market size was valued at USD 30.56 Billion in 2024 and is projected to reach USD 45.14 Billion by 2032, growing at a CAGR of 5% from 2026 to 2032.

Microbial fermentation technology is the controlled development of microorganisms such as bacteria, yeast, or fungi under specified environmental conditions to produce valuable goods. It uses the metabolic capabilities of these microorganisms to convert raw materials into desired molecules using biochemical reactions. Fermentation can take place in either aerobic (with oxygen) or anaerobic (without oxygen) conditions, depending on the microbe and desired result. This technology was originally utilized for food and beverage production, but it has since grown to include medications, chemicals, biofuels, and even biodegradable plastics.

This method is used extensively in a variety of industries. It plays an important role in the manufacture of fermented foods such as yogurt, cheese, and bread. In the pharmaceutical industry, it is used to create antibiotics, vaccines, and therapeutic proteins. Fermentation in the chemical industry yields organic acids, enzymes, and amino acids, which are employed in a variety of products.

Significant expansion and innovation in the microbial fermentation market. Advances in genetic engineering and synthetic biology are improving our ability to evolve and optimize microbial strains for specific products, hence increasing production and efficiency. The transition to sustainable practices and the circular economy is expected to spur additional research and development in microbial fermentation, particularly for bio-based products and renewable energy sources.

Global Microbial Fermentation Technology Market Dynamics

The key market dynamics that are shaping the global microbial fermentation technology market include:

Key Market Drivers:

Growing Demand for Bio-Based Products: The market for microbial fermentation technology is being driven by rising customer demand for sustainable and natural products. According to a US Department of Agriculture report, the global biobased goods market is predicted to reach $487.2 billion by 2024.

Rising Adoption in the Food and Beverage Industry: Microbial fermentation is widely employed in the food and beverage industry, particularly for the manufacture of probiotics and fermented meals. The International Probiotics Association predicts that the global probiotics market will reach $69.3 billion by 2023, expanding at a 7.0% CAGR between 2018 and 2023.

Expanding Applications in the Pharmaceutical Industry: Microbial fermentation is increasingly being used to produce medications such as antibiotics and enzymes. According to the World Health Organization, the worldwide antibiotics industry is expected to be worth $50.37 billion by 2025, with fermentation technologies accounting for a considerable share of output.

Key Challenges:

Process Optimization and Scale-up: One of the main issues is optimizing fermentation operations for optimal productivity, purity, and efficiency. Scaling up production from laboratory to industrial sizes frequently necessitates solving technical challenges such as maintaining stable ambient conditions, assuring sterility, and controlling fermentation kinetics. Variability in raw materials and microbial strains can also hamper scaling efforts, necessitating significant R&D costs.

Product Diversification and Market Demand: Meeting different market needs for new products and applications necessitates ongoing innovation and adaptability. Microbial fermentation technology must keep up with changing customer demands, scientific improvements, and environmental aims. Developing new microbial strains, adjusting fermentation conditions for specific products, and demonstrating superior performance relative to traditional alternatives are all continuous difficulties for market relevance and competitiveness.

Technological Integration and Digitalization: Integrating fermentation processes with digital technologies like automation, artificial intelligence, and big data analytics creates both potential and obstacles. While digitalization can improve process control, efficiency, and product quality, successfully integrating these technologies necessitates significant investment in infrastructure, experience, and data management capabilities.

Key Trends:

Expansion in Biopharmaceuticals: Microbial fermentation is increasingly being used to produce biopharmaceuticals such as antibodies, vaccines, and therapeutic proteins. Advances in genetic engineering and bioprocess optimization allow for the manufacture of complex compounds with higher yields and lower prices, which is boosting the use of microbial fermentation in the biopharmaceutical sector.

Rise of Sustainable and Bio-Based Products: The growing awareness of environmental sustainability is propelling the market toward bio-based products. Microbial fermentation provides a sustainable alternative to standard chemical synthesis processes by converting renewable feedstocks into biodegradable polymers, biofuels, and green chemicals. Consumer preferences for environmentally friendly products, as well as regulatory incentives to promote bioeconomy development, are driving this trend.

Application Diversification: Microbial fermentation is finding new uses outside of established industries like food and pharmaceuticals. Agriculture, cosmetics, textiles, and bioenergy industries are increasingly relying on microbial fermentation to produce enzymes, tastes, perfumes, biopesticides, and biofertilizers. This diversity is fueled by the versatility of microbial fermentation and its capacity to tailor products to suit industrial requirements.

Global Microbial Fermentation Technology Market Regional Analysis

Here is a more detailed regional analysis of the global microbial fermentation technology market:

Asia Pacific:

The Asia Pacific region currently holds the crown for the microbial fermentation technology market. According to UNESCAP, the Asia Pacific region's population is expected to expand rapidly, reaching 4.7 billion by 2050, producing strong demand across a variety of sectors that rely on fermentation technologies. The food and beverage market are primed for tremendous growth.

The region's huge and growing population has resulted in an increase in demand for food and drinks, pharmaceuticals, and industrial enzymes, all of which rely heavily on fermentation.

A growing number of Asian countries are developing as hubs for biopharmaceutical outsourcing, drawing both domestic and foreign firms. This, together with rising disposable income and greater investment in the food and beverage industry, drives the demand for sophisticated fermentation technology.

North America:

North America is expected to be the fastest expanding market for microbial fermentation technologies. North America is seeing a tremendous movement toward sustainable and environmentally friendly products, which is boosting the development of microbial fermentation technological advances. The US Department of Agriculture's bio-preferred program emphasizes the bio-based goods sector's significant economic impact, which contributed $459 billion to the US economy in 2016 and continues to grow.

The National Research Council of Canada predicts that the global market for bio-based chemicals will reach $85.6 billion by 2024, with North America serving as a key driver of this expansion. The findings highlight the region's vital function in developing bio-based solutions using microbial fermentation technologies.

North America leads the way in incorporating precise fermentation processes into food technology. According to the Good Food Institute, North American firms focused on fermentation-enabled alternative proteins raised $1.7 billion in funding in 2021.

The United States Department of Agriculture predicts that by 2030, the global market for alternative proteins, including those obtained from fermentation, will account for 10% of the entire protein industry, representing a $14 billion opportunity. These advancements emphasize North America's critical role in developing the use of precision fermentation to create sustainable and innovative food solutions.

Global Microbial Fermentation Technology Market: Segmentation Analysis

The Global Microbial Fermentation Technology Market is Segmented on the basis of Product Type, Application, And Geography.

Microbial Fermentation Technology Market Segmentation Analysis

Microbial Fermentation Technology Market, By Product Type

• Enzymes
• Antibiotics
• Organic Acids
• Vitamins
• Biopolymer

Based on Product Type, the market is bifurcated into Enzymes, Antibiotics, Organic Acids, Vitamins, and Biopolymers. Antibiotics dominate the microbial fermentation technology market due to established manufacturing methods and strong demand for these life-saving medications. However, the biopolymers segment is predicted to develop the fastest, owing to the growing emphasis on sustainability and the demand for environmentally acceptable alternatives to standard plastics.

Microbial Fermentation Technology Market, By Application

• Pharmaceuticals
• Food & Beverages
• Agriculture
• Industrial Chemicals
• Environmental

Based on Application, the market is segmented into Pharmaceuticals, Food & Beverages, Agriculture, Industrial Chemicals, and Environmental. Due to the increasing demand for biopharmaceuticals such as antibiotics, vaccines, and other therapeutic proteins, the pharmaceutical segment now controls the majority of the microbial fermentation industry. However, the food and beverage industry is predicted to grow the fastest, thanks to the increased popularity of fermented goods such as yogurt and kombucha, as well as plant-based alternatives to meat and dairy.

Key Players

The "Global Microbial Fermentation Technology Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza Group AG, Novozymes A/S, Danone Ltd., Amyris, Inc., Biocon Ltd., TerraVia Holdings, Inc., BioVectra, Inc., and United Breweries Ltd. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Microbial Fermentation Technology Market Recent Developments
• In May 2023, Danone Manifesto Ventures invested in Imagindairy, an Israeli start-up. Thus, the corporation purchased a minority investment in the precision fermentation company.
• In January 2023, BioZyme announced the launching of AO-Biotics. AO, a strain known for its great robustness, is used in the fermentation process by the company to create new fermentation products.
• In September 2022, Genetica, Cargill, and Cyclone Engineers partnered on a project to increase bioreactor fermentation capacity. The National Biotechnology and Biomanufacturing Initiative funded this research with USD 2.5 million.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Enzymes
• 5.3 Antibiotics
• 5.4 Organic Acids
• 5.5 Vitamins
• 5.6 Biopolymer

6 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Pharmaceuticals
• 6.3 Food & Beverages
• 6.4 Agriculture
• 6.5 Industrial Chemicals
• 6.6 Environmental

7 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL MICROBIAL FERMENTATION TECHNOLOGY MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 F. Hoffmann-La Roche AG
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Koninklijke DSM NV
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Lonza Group AG
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Novozymes A/S
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Danone Ltd.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Amyris, Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Biocon Ltd.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 TerraVia Holdings, Inc.
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 BioVectra Inc
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 United Breweries Ltd
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research